InvestorsHub Logo
icon url

drugrunner

09/20/23 2:34 PM

#632862 RE: exwannabe #632858

Ex .. game over for u and your friends

Give it up
icon url

The Danish Dude

09/20/23 2:38 PM

#632863 RE: exwannabe #632858

Straight from Linda Liau. No matter how hard you fud ex, this cuts through your nonsense like shit through a goose.





By
Bullish
Bullish
icon url

Doc logic

09/20/23 2:50 PM

#632866 RE: exwannabe #632858

exwannabe,

Maybe doing this step after freezing is actually less efficient than doing so before freezing and maybe cell selection and exposure to lysate before freezing for storage is even more efficacious and creates greater viability cell count than doing so afterwards. You know like what might be tested for in an equivalence validation process that likely was done loooooonnnnngggg ago hence the claim of sameness by Dr. Linda Liau?; ). You don’t seem to do too well with putting puzzle pieces together correctly. So glad the Lindas and others whose opinions matter in the approval process are good at this. Best wishes.
icon url

Dr Bala

09/20/23 3:03 PM

#632872 RE: exwannabe #632858

I think the ATL DC manufacturing by UCLA is on a small scare whereas the ATL DC manufactured by NWBO can be configured to be on a vary large scale once the approvals are announced. That's the only difference. This topic by the fudster-extraordinaire is ancient. The fudster is reduced to docile fud after the publication of the JAMA data.
icon url

SkyLimit2022

09/20/23 4:22 PM

#632932 RE: exwannabe #632858

ex,

Thanks for the reply. Yes, it is exciting to see immunotherapy combos emerging from clinical trials with brilliant efficacy—Combo is King!

Nobody seems to ever mention the DCVax-L P3 without also mentioning the UCLA combo!

https://www.uclahealth.org/news/fda-approval-brain-cancer-alzheimers

https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
Bullish
Bullish
icon url

Hspooner

09/20/23 5:31 PM

#632972 RE: exwannabe #632858

Give it a rest sport!!!
icon url

jammyjames

09/20/23 6:10 PM

#632988 RE: exwannabe #632858

I normally don't waste my time posting here anymore because of too many dunning-kruger 'experts' like flipper.

I always had you as a someone retired but expert in the field - Here just out of general interest - you're one of the few that genuinely know your shit when it comes to the stats. But my god your desperation shows who you really are (if you're even one person).

As you know but conveniently ignore you infringe on a patent if you use every component of a particular claim. Go through claim 1 of the family of dcvaxl patents. The minor differences of atl-dc do not deviate in the slightest from claim 1 of the dcvaxl patents. I.e dcvax-l claim1 describes atl-dc.

You guys are just trying to scare a few Newby investors!what a joke!
icon url

CherryTree1

09/20/23 7:51 PM

#633045 RE: exwannabe #632858

This is nonsensical

You mean the ATL-DC combo that uses a manufacturing process that makes a separate batch for every patient dose so they can serve it fresh.?

What does that have to do with DCVax-L that uses a single manufacturing run after surgery and freezes the product?


DCVAX-L uses a manufacturing process that makes a separate batch for every patient
If you have a real point to make please make it and be specific because these statements as is are nonsense